Icahn School of Medicine at Mount Sinai
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Icahn School of Medicine at Mount Sinai sits in the top decile of US sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count).
Icahn School of Medicine at Mount Sinai: 708 sponsored US clinical trials, 163 recruiting.
Icahn School of Medicine at Mount Sinai sponsors 708 registered US clinical trials on ClinicalTrials.gov, 163 of them currently recruiting, and 423 completed. 88 of these trials are in Phase 3-4 (later-stage) and 138 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 7 trials.
Top-decile sponsor footprint
Icahn School of Medicine at Mount Sinai ranks in the top decile of sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
423 of 499 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
708 total, page 8 of 15
Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery
NCT03856788
Light and the Effect on Metabolic Syndrome and Alzheimer's Disease
NCT03777722
Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)
NCT03521687
Improving Medication Adherence in Adolescents Who Had a Liver Transplant
NCT03691220
Palliative Care at Home for Dementia
NCT03798327
Intraoperative Video Laryngoscopy as Adjunct for Nerve Monitoring
NCT03742141
Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations
NCT03669939
Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease
NCT04988204
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
NCT03689452
Trial of Mount Sinai Palliative Care at Home
NCT03793803
Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily?
NCT03595982
Daily vs Alternate Day Iron Supplementation for Pregnant Women With Iron Deficiency Anemia
NCT03562143
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment
NCT03572387
Comparison of Analgesic Efficacy Between of Interscalene Block With Liposomal Bupivacaine With Bupivacaine and Dexamethasone
NCT03969875
Prophylactic NPWT to Reduce SSI in Colorectal Surgery
NCT03661814
Efficacy Of Quadratus Lumborum II Block For Laparoscopic Sleeve Gastrectomy
NCT04073056
Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
NCT03341806
Thromboelastometry Prediction Utility for Risk of Abortion
NCT03548701
Assessing the Impact of Mount Sinai Parenting Center's Newborn Class
NCT04121390
Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color
NCT03506477
Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).
NCT03485222
Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCL
NCT03305445
The Liver in the World Trade Center Health Program General Responder Cohort and Controls
NCT03858920
Improving Cognition Via Exercise in Schizophrenia
NCT03270098
Online Emotion Regulation Group Intervention
NCT03479606
CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation
NCT03657108
Assessment of Portal Hypertension With Multiparametric MRI
NCT03436550
Adrenocorticotropic Hormone in Membranous Nephropathy
NCT03025828
SURE 18 Registry -Asahi Chikai Black 18 in LVO Stroke
NCT03438565
Efficacy of Tranexamic Acid in Foot and Ankle Surgeries
NCT03653429
Efficacy of Ipack Block and Surgeon's Joint Infiltration in Total Knee Arthroplasty
NCT03653416
Efficacy Between Serratus Plane Block And Local Infiltration In Vats
NCT03642457
Reducing the Duration of Untreated Psychosis in the United States
NCT03369730
Does Ultrasound Help Junior Anesthesia Residents With Placement of Labor Analgesia in Pregnant Patients
NCT02747238
Systematic Light Exposure for Fatigue in Breast Cancer Patients
NCT03217201
Eliminating Hepatitis C Virus
NCT03401697
Investigating the Effect of Acupressure on Shivering During a Cesarean Delivery in Women Who Were Previously Laboring With an Epidural
NCT03497507
Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
NCT03359356
Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients
NCT03348683
Does Adding an Additional Numbing Medication Injection in the Thigh Help With Pain Control After Knee Replacement Surgery?
NCT03326999
Internet-Based Motivational Interviewing for Colonoscopy
NCT03595904
Anxiety About Casual Exposure to Food Allergens
NCT03349047
World Trade Center Kidney-Link
NCT03234530
Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies
NCT03403036
Assessing Pyridium for Post-Sling Urinary Retention
NCT03302936
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
NCT03297021
Local Infusion of Ropivacaine for Post-Op Pain Control After Osseocutaneous Free Flaps
NCT03349034
Evaluation of Video Laryngoscopy in Patients With Head and Neck Pathology
NCT03265938
Response to Anti-hypertensives in Pregnant and Postpartum Patients
NCT03506724
Online Therapy for Posttraumatic Stress Symptoms in WTC Responders and Survivors
NCT03154151
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 81 |
| Phase 3 | 21 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Icahn School of Medicine at Mount Sinai pipeline
163 recruiting of 708 indexed (23% open); 423 completed (60%).
Phase mix: 88 late (III/IV) vs 138 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Icahn School of Medicine at Mount Sinai: open-pipeline peers nationwide
Peers matched on 708 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Icahn School of Medicine at Mount Sinai sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 708 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
- University of Miami · 721 trials · 20% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Icahn School of Medicine at Mount Sinai page
708 registered trials is a research-attention snapshot, not an endorsement of Icahn School of Medicine at Mount Sinai or any single study.
- 163 of Icahn School of Medicine at Mount Sinai's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Icahn School of Medicine at Mount Sinai studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Icahn School of Medicine at Mount Sinai pipeline card: 708 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.